Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

111 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Amifostine: potential for clinically useful cytoprotection.
Budd GT, Lorenzi V, Ganapathi R, Adelstein D, Pelley R, Olencki T, McLain D, Bukowski RM. Budd GT, et al. Among authors: olencki t. Support Care Cancer. 1994 Nov;2(6):380-4. doi: 10.1007/BF00344052. Support Care Cancer. 1994. PMID: 7858931 Review.
Interleukin-2: use in solid tumors.
Bukowski RM, McLain D, Olencki T, Budd GT, Murthy SA. Bukowski RM, et al. Among authors: olencki t. Stem Cells. 1993 Jan;11(1):26-32. doi: 10.1002/stem.5530110106. Stem Cells. 1993. PMID: 8457777 Review.
Phase II trial of interleukin-2 and interferon-alpha in patients with renal cell carcinoma: clinical results and immunologic correlates of response.
Bukowski RM, Olencki T, Wang Q, Peereboom D, Budd GT, Elson P, Sandstrom K, Tuason L, Rayman P, Tubbs R, McLain D, Klein E, Novick A, Finke J. Bukowski RM, et al. Among authors: olencki t. J Immunother. 1997 Jul;20(4):301-11. doi: 10.1097/00002371-199707000-00007. J Immunother. 1997. PMID: 9220320 Clinical Trial.
111 results